The association of sleep duration with the risk of chronic kidney disease: a systematic review and meta-analysis
Clinical Kidney Journal · 01.08.2024 · 17 (8)
DOI: 10.1093/ckj/sfae177 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical Kidney Journal, online erschienen am 11.07.2024. Verfasst von Jin Hean Koh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and hypothesis Published literature suggests that sleep duration and quality may be affected in adults with chronic kidney disease. However, the relationship between these two entities remains a matter of debate. The objective of this systematic review and meta-analysis is to assess the effect of sleep duration and quality on chronic kidney disease.
Methods
A systematic review of the Medline/PubMed, Embase, Cochrane Library, and CINAHL databases was conducted for articles pertaining to the association between sleep duration and quality on chronic kidney disease. The main outcome was the hazard/risk ratio of chronic kidney disease in patients of varying sleep durations and quality.
Results
In total, 42 studies (2 613 971 patients) with a mean age of 43.55 ± 14.01 years were included in the meta-analysis. Compared with a reference range of 7 to 8 hours of sleep, short sleep durations of ≤4 hours (RR 1.41, 95% CI: 1.16 to 1.71, P < 0.01), ≤5 hours (RR 1.46, 95% CI: 1.22 to 1.76, P < 0.01), ≤6 hours (RR 1.18, 95% CI: 1.09 to 1.29, P < 0.01), and ≤7 hours (RR 1.19, 95% CI: 1.12 to 1.28, P < 0.01) were significantly associated with an increased risk of incident chronic kidney disease. Long sleep durations of ≥8 hours (RR 1.15, 95% CI: 1.03 to 1.28, P < 0.01) and ≥9 hours (RR 1.46, 95% CI: 1.28 to 1.68, P < 0.01) were also significantly associated with an increased risk of incident chronic kidney disease. Meta-regression did not find any significant effect of age, gender, geographical region, and BMI and an association with sleep duration and risk of incident chronic kidney disease.
Conclusion
Both short and long sleep durations were significantly associated with a higher risk of chronic kidney disease. Interventions targeted toward achieving an optimal duration of sleep may reduce the risk of incident chronic kidney disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
- Department of Otorhinolaryngology-Head and Neck Surgery, Singapore General Hospital, Singapore, Singapore.
- Singhealth Duke-NUS Sleep Centre, Duke-NUS Medical School, Singapore, Singapore.
- Department of Renal Medicine, Singapore General Hospital, Singapore, Singapore.
ORCID-Profile: Jin Hean Koh, Joshua Gooley
Zitieren
APA
Koh, J. H., Yeo, B. S. Y., Tan, T. W. E., See, M. Y. S., Ng, A. C. W., Loh, S. R. H., Gooley, J., Tan, C. S., & Toh, S. T. (2024). The association of sleep duration with the risk of chronic kidney disease: a systematic review and meta-analysis. Clinical Kidney Journal, 17(8). https://doi.org/10.1093/ckj/sfae177
Vancouver
Koh JH, Yeo BSY, Tan TWE, See MYS, Ng ACW, Loh SRH, et al. The association of sleep duration with the risk of chronic kidney disease: a systematic review and meta-analysis. Clinical Kidney Journal. 2024;17(8). doi:10.1093/ckj/sfae177
BibTeX
@article{Koh2024,
author = {Koh, Jin Hean and Yeo, Brian Sheng Yep and Tan, Timothy Wei En and See, Mark Yong Siang and Ng, Adele Chin Wei and Loh, Shaun Ray Han and Gooley, Joshua and Tan, Chieh Suai and Toh, Song Tar},
title = {The association of sleep duration with the risk of chronic kidney disease: a systematic review and meta-analysis},
journal = {Clinical Kidney Journal},
year = {2024},
volume = {17},
number = {8},
doi = {10.1093/ckj/sfae177}
}
EUVIMED